AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Because my Lent took a nosedive about two-thirds of the way through, I am still immersed in a project I undertook in order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results